Skip to main content
Back to Kleiner Perkins

Kleiner Perkins's Biotechnology Portfolio

Browse 4 Biotechnology companies funded by Kleiner Perkins. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
4
Total Funding in Biotechnology
$562.9M

Biotechnology Portfolio Companies (4)

Export
BiotechnologyClinical TrialsHealth Care

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

South San Francisco, United States
October 2025
$45.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.

San Diego, United States
January 2023
$6.9M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth Care

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

South San Francisco, United States
December 2025
$261.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

South San Francisco, United States
October 2025
$250.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore Kleiner Perkins's Full Portfolio

View all companies funded by Kleiner Perkins across every industry and funding stage.

View Full Kleiner Perkins Portfolio